These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 661844)

  • 21. LM-Ag and LSP--two different target antigens involved in the immunopathogenesis of chronic active hepatitis?
    Meyer zum Büschenfelde KH; Manns M; Hütteroth TH; Hopf U; Arnold W
    Clin Exp Immunol; 1979 Aug; 37(2):205-12. PubMed ID: 498582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Liver cell membrane autoantibody (LMA) in chronic liver disease].
    Garagnani M; Meliconi R; Mazzoli M; Stancari V; Mariani AR; Morabito F; Miglio F; Facchini A
    Boll Soc Ital Biol Sper; 1980 Aug; 56(15):1585-9. PubMed ID: 7459079
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liver specific autoimmunity and chronic liver disease--an enigmatic relationship.
    Nayak NC; Tandon BN
    Ann Acad Med Singap; 1980 Apr; 9(2):172-5. PubMed ID: 6999970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Chronic HBsAg negative hepatitis in childhood, Stud using the immunofluorescence method].
    Calzia R; Ciravegna B; Navone C; Tolentino P
    Boll Ist Sieroter Milan; 1981 Jul; 60(3):176-87. PubMed ID: 7034745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Double-stranded DNA-binding capacity of serum in acute and chronic liver disease.
    Jain S; Markham R; Thomas HC; Sherlock S
    Clin Exp Immunol; 1976 Oct; 26(1):35-41. PubMed ID: 1087214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential distribution of hepatitis B surface antigen and hepatitis B core antigen in the liver of hepatitis B patients.
    Ray MB; Desmet VJ; Bradburne AF; Desmyter J; Fevery J; De Groote J
    Gastroenterology; 1976 Sep; 71(3):462-9. PubMed ID: 59675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Naturally occurring serum antiidiotypic antibody against antiliver-specific membrane lipoprotein in patients with hepatitis.
    Tsubouchi A; Yoshioka K; Kakumu S
    Hepatology; 1985; 5(5):752-7. PubMed ID: 3875542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppressor cell activity in viral and non-viral chronic active hepatitis.
    Tremolada F; Fattovich G; Panebianco G; Ongaro G; Realdi G
    Clin Exp Immunol; 1980 Apr; 40(1):89-95. PubMed ID: 6446433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Species cross-reactivity of anti-LSP antibodies in acute viral hepatitis.
    Perperas A; McFarlane BM; McSorley CG; McFarlane IG; Williams R
    J Clin Lab Immunol; 1986 Jan; 19(1):25-30. PubMed ID: 2422379
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-LSP antibodies in acute liver disease.
    Meliconi R; Perperas A; Jensen D; Alberti A; McFarlane IG; Eddleston AL; Williams R
    Gut; 1982 Jul; 23(7):603-7. PubMed ID: 7084806
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lymphocyte transformation test with rabbit liver specific lipoprotein (RLSP) in chronic active hepatitis.
    Ortona L; Laghi V; Cauda R; Nervo P
    Clin Exp Immunol; 1979 Nov; 38(2):231-4. PubMed ID: 527260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Autoantibodies to liver membrane in children with chronic active hepatitis (author's transl)].
    Chauvel Y; Fernandez-Tello DS; Frommel D
    Arch Fr Pediatr; 1980; 37 Suppl 2():V-VII. PubMed ID: 7447613
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fractionation of the liver membrane lipoprotein (LSP) and characterisation of its antigenic determinants by autoantibodies and a heterologous anti-serum.
    Manns M; Meyer zum Büschenfelde KH
    Gut; 1982 Jan; 23(1):14-20. PubMed ID: 6173289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibody-dependent cell-mediated (K cell) cytotoxicity against isolated hepatocytes in chronic active hepatitis.
    Cochrane AM; Moussouros A; Thomsom AD; Eddleston AL; Wiiliams R
    Lancet; 1976 Feb; 1(7957):441-4. PubMed ID: 55716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Liver-specific proteins and autoimmunity in inflammatory liver diseases].
    Alberti A; Realdi G; Bortolotti F; Trevisan A; Tremolada F; Rigoli A
    Boll Ist Sieroter Milan; 1976; 55(5):411-25. PubMed ID: 1016592
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell-mediated immune reactivity to hepatitis B surface antigen in liver diseases.
    de Moura MC; Vernace SJ; Paronetto F
    Gastroenterology; 1975 Aug; 69(2):310-17. PubMed ID: 1080122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inadequate antibody response to hBAg or suppressor T-cell defect in development of active chronic hepatitis.
    Eddleston AL; Williams R
    Lancet; 1974 Dec; 2(7896):1543-5. PubMed ID: 4140983
    [No Abstract]   [Full Text] [Related]  

  • 38. A histologic comparison of hepatitis B with non-A, non-B chronic active hepatitis.
    Thorne CH; Higgins GR; Ulich TR; Gitnick GL; Lewin KJ
    Arch Pathol Lab Med; 1982 Sep; 106(9):433-6. PubMed ID: 6810841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of HBsAg on the membrane of hepatocytes in chronic carriers of hepatitis B virus infection.
    Realdi G; Trevisan A; Alberti A; Losi C; Rigoli AM; Rugge M; Pornaro E
    J Clin Lab Immunol; 1978 Nov; 1(3):201-5. PubMed ID: 387960
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibodies to a human liver membrane lipoprotein (LSP) in primary biliary cirrhosis.
    Tsantoulas D; Perperas A; Portmann B; Eddleston AL; Williams R
    Gut; 1980 Jul; 21(7):557-60. PubMed ID: 7429318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.